Evidence map›Paper›PMID 31860744›Full record

ArticleHepatology (Baltimore, Md.)2020

Moesin, an Ezrin/Radixin/Moesin Family Member, Regulates Hepatic Fibrosis.

Serhan Karvar, Ephraim A Ansa-Addo, Jo Suda, Shweta Singh, Lixin Zhu, Zihai Li, Don C Rockey

Open access · greenAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. [Clinical significance and pathogenesis analysis of Moesin in multiple myeloma].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2023
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Serhan KarvarDivision of Gastroenterology and Hepatology, Department of Medicine, Medical University of South Carolina, Charleston, SC.
Ephraim A Ansa-AddoDepartment of Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC.
Jo SudaDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA.
Shweta SinghDepartment of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, SC.
Lixin ZhuGuangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Department of Colorectal Surgery, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Zihai LiDepartment of Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC.
Don C RockeyDivision of Gastroenterology and Hepatology, Department of Medicine, Medical University of South Carolina, Charleston, SC.
Medical University of South Carolina · USCedars-Sinai Medical Center · USUniversity at Buffalo, State University of New York · US

Funding

The role of SMAD1 and SATB2 in colon patterningP20GM130457 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Hailong Zhang · 2020 to 2026
$18.7M
Proteomics CoreP30DK123704 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DON C. ROCKEY · 2020 to 2026
$8.8M
Project 3: Structural Basis for grp94 Drug Development and Chaperone FunctionP01CA186866 · NCI · OHIO STATE UNIVERSITY · PI LI, ZIHAI · 2015 to 2019
$6.7M
A Molecular Approach to the Pathogenesis of Portal HypertensionR01DK113159 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DON C. ROCKEY · 2017 to 2026
$2.7M
The Cell and Molecular Biology of Myofibroblasts in Hepatic FibrosisR01DK098819 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ROCKEY, DON C. · 2014 to 2017
$1.3M
NCI NIH HHS P01 CA186866NIDDK NIH HHS P30 DK123704NIDDK NIH HHS R01 DK098819NIDDK NIH HHS R01 DK113159NIGMS NIH HHS P20 GM130457
6 · The paper itself

Abstract

BACKGROUND AND

aimsMoesin, an ezrin/radixin/moesin family member, is involved in the regulation of cell adhesion, polarity, and migration by cross-linking between the actin cytoskeleton and plasma membrane. The primary effector cell in hepatic fibrosis is the hepatic stellate cell (HSC), which undergoes activation during liver injury leading to increased extracellular matrix production. APPROACH AND

resultsHere, we have hypothesized that moesin plays a critical role in linking the HSC cytoskeleton to the fibrogenic cascade during HSC activation. Moesin phosphorylation was up-regulated during HSC activation and fibrogenesis. Using moesin wild-type (WT) and mutant constructs (phosphomimicking T558D and nonphosphorylatable T558A), we found that cellular motility and contraction were increased in moesin WT-infected and T558D-infected cells, paralleled by an increase in smooth muscle α-actin and collagen 1 expression. In contrast, overexpression of nonphosphorylatable moesin and moesin knockout (KO) decreased cellular motility and contraction. Most importantly, moesin KO led to abrogation of liver fibrosis. The mechanism of moesin's effect was a reduction in myocardin-related transcription factor-A and serum-response factor (SRF)-mediated changes in the actin cytoskeleton, which in turn modulated the expression of matrix genes.

conclusionsTaken together, our findings suggest that the linkage between cytoskeletal dynamics and the correlated MRTF/SRF signaling pathway has a pivotal role in HSC activation and fibrogenesis.

Indexed as

Hepatic Stellate CellsLiver CirrhosisActin CytoskeletonAnimalsCell AdhesionCell MembraneCell MovementCell PolarityDisease Models, AnimalExtracellular MatrixMiceMice, KnockoutMicrofilament ProteinsPeptide FragmentsPhosphorylationRatsMicrofilament ProteinsmoesinMrtfa protein, mouseMrtfa protein, ratPeptide FragmentsSerum Response Factorserum response factor, ratSrf protein, mouseTrans-ActivatorsTranscription Factors

Identifiers

PMID31860744
PMCPMC7437180
OpenAlexW2996742194

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.